Resaas now selling COVID-19 tests on-line in Australia RESAAS LAUNCHES AUSTRALIAN ONLINE ORDERING OF COVID-19 RAPID TESTS
Resaas Services Inc. has launched on-line ordering of COVID-19 rapid tests in Australia.
Black Friday Sale https://store.resaas.com/ RESAAS/QuestCap partnership should be adding more revenue on top of testing sites.
The rapid tests are authorized by the Therapeutic Goods Administration (TGA), the regulatory body under Australia's Department of Health.
- Australian customers can order on-line via Resaas's secure e-commerce store.
- Express shipping is provided by DHL.
- Tests are priced between $75 (Australian) and $90 (Australian) each, depending on volume.
- Available in quantities of six, 12 and 24 packs.
- Presents results in eight minutes.
- Also concludes if the antibody is present.
- Easy-to-read finger-priick tests proven to be 98-per-cent accurate.
"Following the successful launch of on-line ordering and home delivery of COVID-19 rapid tests to Resaas customers based in the United States of America, Resaas is proud to quickly bring this solution to the Australian market," said Resaas chief executive officer Tom Rossiter. "Australia has approximately 65,000 licensed real estate agents, several of which are existing Resaas subscribers. Enabling Australians to order rapid tests directly to their offices or homes will offer them a powerful solution to restore the business of real estate responsibly."
The company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 coronavirus) at this time.
At present, the TGA requires all rapid test kits be used in accredited laboratories, by registered medical practitioners, or health care professionals in residential and aged care facilities. Upon receiving rapid test kits, the company recommends contacting a local test centre to schedule an appointment.
https://corporate.resaas.com/news-releases/2020/08/26/resaas-and-questcap-enter-into-commercial-agreement-to-sell-fda-eua-covid-19-igg-igm-antibody-tests/